Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 10.12.2006

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
10.12.06VELCADE(R) (Bortezomib) for Injection Combination Shows High Complete and Near Complete Response Rate in Preliminary Data From Phase III Front-Line Multiple Myeloma Trial26ORLANDO, Fla., Dec. 10 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today reported that the Intergroupe Francophone du Myelome (IFM) cooperative group presented preliminary data from...
► Artikel lesen
10.12.06CIGNA HealthCare Supports U.S. Senate and House Bipartisan Effort to Make Consumer Health Coverage More Affordable, Accessible and Flexible11BLOOMFIELD, Conn., Dec. 10, 2006 /PRNewswire-FirstCall/ -- CIGNA HealthCare today announced its support of the bipartisan efforts of the House and Senate to make health care more affordable, accessible...
► Artikel lesen
10.12.06Preliminary Results from Sunesis Pharmaceuticals' Phase 1 Trial of SNS-595 in Patients with Advanced Leukemias Demonstrate Promising Clinical Activity12SOUTH SAN FRANCISCO, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. presented data on its lead compound, SNS-595, from an ongoing Phase 1 clinical trial and from preclinical...
► Artikel lesen
10.12.06Dynavax Reports Positive Phase 2a NHL Data at ASH Meeting11BERKELEY, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation announced today preliminary data from an ongoing open label Phase 2a study of the company's TLR9 agonist used in...
► Artikel lesen
10.12.06Novel Protein Constructs Active Against Lymphoma In Animal Models10ORLANDO, Fla., Dec. 10 /PRNewswire-FirstCall/ -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies, today announced the development of new multivalent antibodies...
► Artikel lesen
10.12.06Elron Announces Completion by Galil Medical Of $52 Million Financing and Acquisition of Oncura's Urology Related Cryotherapy Business20TEL AVIV, Israel, Dec. 10 /PRNewswire-FirstCall/ -- Elron Electronic Industries Ltd. , announced today that further to its previous announcements, Galil Medical Ltd., ("Galil Medical"), an Elron group...
► Artikel lesen
10.12.06ATK Propulsion Supports the Successful Launch of Space Shuttle Discovery10MINNEAPOLIS, Dec. 9 /PRNewswire-FirstCall/ -- Alliant Techsystems' reusable solid rocket motors (RSRM) performed flawlessly earlier this evening as NASA's Space Shuttle Discovery launched into orbit...
► Artikel lesen